menu
    • menu

    Company profile for PepGen

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of our innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and we are advancing novel conjugate therapeutics to the clinic. PepGen’s ambition is to harness the power of peptide conjugation technologies in order to ad...
    Our ambition is to unlock the potential of nucleic acid therapeutics by leveraging the drug delivery capabilities of our innovative product engine. PepGen's initial focus is on the application of this technology to the efficacious delivery of antisense oligonucleotides, and we are advancing novel conjugate therapeutics to the clinic. PepGen’s ambition is to harness the power of peptide conjugation technologies in order to address the delivery challenge associated with nucleic acid therapeutics and thus realise the clinical potential of these transformative therapeutics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PepGenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 Main St, Cambridge, MA 02142
    Telephone
    Telephone
    +44 1865 618 820
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pepgen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PepGen Stock Halves on Mixed Data in Rare Muscle Disease
    PepGen Stock Halves on Mixed Data in Rare Muscle Disease

    31 Mar 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/pepgen-loses-half-of-share-price-on-mixed-data-in-rare-muscle-wasting-disease

    BIOSPACE
    31 Mar 2026
    Share Share
    PepGen 5 mg/kg Ph2 FREEDOM2 Shows Safety Splicing vHOT Data
    PepGen 5 mg/kg Ph2 FREEDOM2 Shows Safety Splicing vHOT Data

    30 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330100190/en/PepGen-Announces-Topline-Results-from-Lowest-Dose-5-mgkg-MAD-Cohort-in-the-Ongoing-Phase-2-FREEDOM2-Study-Demonstrating-Favorable-Safety-Splicing-and-vHOT-Data

    BUSINESSWIRE
    30 Mar 2026
    Share Share
    PepGen Reports Fourth Quarter and Year-End 2025 Financial Results
    PepGen Reports Fourth Quarter and Year-End 2025 Financial Results

    04 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260304670027/en/PepGen-Reports-Fourth-Quarter-and-Year-End-2025-Financial-Results-and-Recent-Corporate-Highlights

    BUSSINESSWIRE
    04 Mar 2026
    Share Share
    Pepgen Announces Regulatory Updates On FREEDOM2
    Pepgen Announces Regulatory Updates On FREEDOM2

    04 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260304006219/en/PepGen-Announces-Regulatory-Updates-on-FREEDOM2

    BUSSINESSWIRE
    04 Mar 2026
    Share Share
    PepGen To Participate In The Leerink Global Healthcare Conference
    PepGen To Participate In The Leerink Global Healthcare Conference

    03 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-03/pepgen-to-participate-in-the-leerink-global-healthcare-conference

    PHARMIWEB
    03 Mar 2026
    Share Share
    PepGen Grants Inducement to New Chief Business Officer
    PepGen Grants Inducement to New Chief Business Officer

    09 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-09/pepgen-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-to-newly-appointed-chief-busine

    PHARMIWEB
    09 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search